D-1539-2022 Class II Terminated
FDA drug recall D-1539-2022 was initiated by Teva Pharmaceuticals USA Inc on Aug 29, 2022 and is designated Class II. Reason for recall: Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product. The recall status is terminated (terminated Aug 14, 2023). Affected quantity: 83,703 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 21, 2022
- Initiation Date
- Aug 29, 2022
- Termination Date
- Aug 14, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 83,703 bottles
Product description
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, Rx Only, 100 tablets per bottle, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0555-0777-02.
Reason for recall
Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.
Distribution pattern
Nationwide in the US.
Code information
Lot #: 100023340, Exp 10/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1539-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026